Founded in 1998, MicroDose Therapeutx is a private pharmaceutical company successfully pioneering the creation of next-generation products utilizing its proprietary drug delivery technologies. In the pipeline, its Dry Powder Inhaler, Dry Powder Nebulizer, PolyCap™ systems, and Needlefree technologies promise to dramatically improve efficacy and compliance. MicroDose’s exceptional, multi-disciplinary team and partners are dedicated to delivering these innovative products to help transform the lives of patients suffering from a wide range of debilitating diseases including asthma, COPD, RSV, IBS-C, and constipation.
MicroDose Therapeutx is committed to:
- Creating superior products utilizing its revolutionary drug delivery technologies; and
- Collaborating with top-tier pharmaceutical and biotechnological partners to develop innovative products.